An Episode Highlight from The Path to KOLs: Investing in Innovation — A Conversation with Sam Libby of TCB Capital Advisors

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/25/a3/05/25a3058e-493c-db01-6181-3cad0515ad9c/mza_16193196729824322971.jpg/600x600bb.jpg

"Lecture-casts"- A Lecture Series on General Chemistry

Mr. D.J. Ferguson, BS, MS, BCMAS, MRSB MRSC

121 episodes

3 days ago

Are you interested in learning about General Chemistry ! Are you passionate about science and want to learn about it in a fun and engaging way! Check out " Lecture-casts"- A Podcast Lecture Series in Chemistry" on Spotify! Don't forget to subscribe! We are grateful to have some of the best science educators and thought leaders! Thanks.

Chemistry

Science

RSS

All content for "Lecture-casts"- A Lecture Series on General Chemistry is the property of Mr. D.J. Ferguson, BS, MS, BCMAS, MRSB MRSC and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Chemistry

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40127158/3391331d5408e644.jpeg

An Episode Highlight from The Path to KOLs: Investing in Innovation — A Conversation with Sam Libby of TCB Capital Advisors

"Lecture-casts"- A Lecture Series on General Chemistry

29 minutes 50 seconds

2 months ago

An Episode Highlight from The Path to KOLs: Investing in Innovation — A Conversation with Sam Libby of TCB Capital Advisors

🎙️ Episode Description

In this episode, we sit down with Sam Libby,President and Managing Director at TCB Capital Advisors, whose career has been dedicated to transforming healthcare through strategic investments andpartnerships. With more than 30 completed transactions —spanning mergers and acquisitions, capital raises, and innovative deal structures—Sam has become a trusted advisor at the intersection of finance, science, and patient care. Our conversation dives deep into his origin story—from Rutgers to leading one of the most dynamic advisory firms in healthcare—and explores how his investment philosophy balances patient-centered missions withthe financial discipline demanded by markets. Sam shares case studies from groundbreaking ventures like Clairity, the first FDA-cleared AI breast cancer risk platform, and Altoida, a pioneer in early cognitive assessment technology, offering valuable lessons for founders and investors alike.

We also discuss the critical role of strategicpartnerships, the evolving dynamics between founders and investors, and the exciting frontiers shaping the future of healthcare—from oncology and neurodegeneration to women’s health and digital innovation. Sam highlights how AI and data are reshaping deal-making, due diligence, and commercialization pathways. Finally, Sam offers practical advice for aspiring thought leaders and entrepreneurs on refining their pitch, stepping into leadership beyond the lab, and positioning themselves for long-term impact in arapidly evolving industry.

Whether you’re a scientist, entrepreneur, investor, orfuture healthcare leader, this episode provides insightful perspectives on the business of innovation, the art of deal-making, and the mission to improve patient outcomes.